Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prospero Health is a physician-led provider of home-based medical and palliative care for people with serious illness. The company delivers both in-person and telehealth services in 28 states, focusing on holistic, compassionate support for complex patient populations. Prospero was acquired by UnitedHealth Group's Optum in January 2022 and merged with Landmark Health to form a major national provider of home-based care, serving more than 30,000 patients pre-merger and anticipated to reach an average daily census of ~200,000 post-merger across 37 states[3][4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prospero Health.